FOXA1 and thyroid gland carcinoma: Duan L. et al. studied the in vitro anticancer effects of OA on SW579 human thyroid carcinoma cell lines; the molecular mechanism involved was revealed as the inhibition of the FOXA1 signaling pathway that succeeded in reducing the viability of SW579 cell lines in a dose-dependent manner.